Skip to content
Skip to navigation menu
23 January 2014
Genetic mutations in people with schizophrenia cluster in specific proteins offering a ‘new window’ into the disorder, according to University scientists.
In the largest genetic study of its kind, published in the journal Nature, an international team examined the occurrence of new genetic mutations in people with schizophrenia.
Working alongside teams from leading research institutions they examined DNA blood samples from 623 sufferers and their parents.
The study showed that "de novo" mutations, which are found in affected individuals but not their parents, play a role in triggering the disorder but more importantly that they preferentially disrupt specific sets of proteins which have related functions in the brain.
These pathways are involved in modulating the strength of connections between nerve cells and play important roles in brain development, learning, memory and cognition.
"We already had evidence from previous work in Cardiff supporting the importance of these pathways but the new findings, together with those from another study published in the same issue of Nature, confirm the importance of these and related sets of proteins," according to Professor Mike Owen from the University’s MRC Centre for Neuropsychiatric Genetics and Genomics based in the School of Medicine, who co-led the research.
"This degree of convergence from several studies is unprecedented in schizophrenia genetics and tells us that for the first time we have a handle on one of the core brain processes that is disrupted in the disorder," he adds.
As well as identifying how genetic mutations impact on brain function the findings also indicate an overlap with the causes of other neurodevelopmental disorders including autism and intellectual disability.
Professor Mick O’Donovan, who jointly led the research added: "The fact we’ve been able to identify a degree of overlap between the underlying causes of schizophrenia and those in autism and intellectual disability suggests that these disorders might share some common mechanisms and lends further weight to calls for research that integrates findings across multiple disorders.
"We need research that takes into account genetics, cognitive science, imaging and other sources of information rather than relying solely on clinical definitions for psychiatric disorders."
Professor Hugh Perry, Chair of the MRC Neurosciences and Mental Health Board said: "Understanding how our genetic code contributes to Schizophrenia is crucial if we are to develop better, safer treatments. This study adds a body of rapidly emerging research being funded by the Medical Research Council on the role of the genome in mental illness. Such advances in developmental biology will help us to unravel the complexity of emotional and behavioural disturbances."
Mark Drakeford AM Minister for Health and Social Services: "These important findings represent another significant step to understanding the neurobiology of schizophrenia. The pivotal role played by researchers at the MRC Centre, which is partly funded by the National Institute for Social Care and Health Research, highlights their expertise and world-leading reputation in this field."
Professor Jon Bisson, Head National Institute for Social Care and Health Research (NISCHR) added: "It is great to witness further major discoveries being made by the MRC Centre. These exciting findings are likely to have a major impact on the direction of future research in this area that will ultimately allow the development of more effective treatments."
School of Medicine
The MRC Centre for Neuropsychiatric Genetics and Genomics
Creative Citizens come together
Meeting of economic minds
Cardiff University spin-out company to float on the London stock exchange
Cartooning the First World War
Flagship centre secures funding renewal
Can people with type 2 diabetes live longer?
This is an externally hosted beta service offered by Google.